We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
PUT
Marvell Technology
MRVL
$161B
| $325K | 0.02% |
+13,000
| New | +$326K |
|
952
CALL
Tradeweb Markets
TW
$22.2B
| $325K | 0.02% |
8,800
-14,200
| -62% | -$627K |
|
|
GTLS
953
CALL
DELISTED
Chart Industries
GTLS
| $324K | 0.02% |
+5,200
| New | +$352K |
|
954
PUT
Lattice Semiconductor
LSCC
$16.5B
| $324K | 0.02% |
+17,700
| New | +$324K |
|
955
Green Dot
GDOT
$757M
| $323K | 0.02% |
12,800
+12,330
| +2,623% | +$456K |
|
956
PUT
US Bancorp
USB
$99.6B
| $321K | 0.02% |
+5,800
| New | +$313K |
|
|
BIG
957
PUT
DELISTED
Big Lots, Inc.
BIG
| $321K | 0.02% |
+13,100
| New | +$312K |
|
958
CALL
S&P Global
SPGI
$129B
| $318K | 0.02% |
1,300
-300
| -19% | -$75K |
|
959
Anika Therapeutics
ANIK
$203M
| $317K | 0.02% |
+5,782
| New | +$297K |
|
960
PUT
Inogen
INGN
$174M
| $316K | 0.02% |
6,600
+1,300
| +25% | +$67.8K |
|
961
CALL
Levi Strauss
LEVI
$9.69B
| $316K | 0.02% |
+16,600
| New | +$308K |
|
|
USCR
962
CALL
DELISTED
U S Concrete, Inc.
USCR
| $315K | 0.02% |
5,700
+2,000
| +54% | +$93.5K |
|
|
CCX.U
963
DELISTED
Churchill Capital Corp II
CCX.U
| $315K | 0.02% |
30,000
| – | – |
|
964
PUT
Stratasys
SSYS
$696M
| $313K | 0.02% |
+14,700
| New | +$371K |
|
965
PUT
Core Laboratories
CLB
$510M
| $312K | 0.02% |
+6,700
| New | +$311K |
|
966
CALL
Regenxbio
RGNX
$606M
| $310K | 0.02% |
+8,700
| New | +$353K |
|
967
CALL
G-III Apparel Group
GIII
$1.55B
| $309K | 0.02% |
12,000
+1,700
| +17% | +$42.6K |
|
|
XLNX
968
PUT
DELISTED
Xilinx Inc
XLNX
| $307K | 0.02% |
3,200
+1,600
| +100% | +$175K |
|
969
CALL
Boston Scientific
BSX
$69.2B
| $305K | 0.02% |
+7,500
| New | +$318K |
|
970
CALL
NiSource
NI
$22.2B
| $305K | 0.02% |
10,200
-10,400
| -50% | -$305K |
|
971
CALL
Trip.com Group
TCOM
$28.8B
| $305K | 0.02% |
10,400
+6,500
| +167% | +$229K |
|
972
United Natural Foods
UNFI
$3.08B
| $304K | 0.02% |
26,400
+13,900
| +111% | +$133K |
|
973
Gogo Inc
GOGO
$536M
| $303K | 0.02% |
50,200
+39,200
| +356% | +$185K |
|
974
PUT
Tenet Healthcare
THC
$21.9B
| $303K | 0.02% |
13,700
-700
| -5% | -$14.9K |
|
|
GHL
975
CALL
DELISTED
Greenhill & Co., Inc.
GHL
| $303K | 0.02% |
+23,100
| New | +$330K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.